跳至主要内容
临床试验/NCT05437575
NCT05437575招募中3 期

Prehospital Analgesia INtervention Trial (PAIN)

Jason Sperry19 个研究点 分布在 1 个国家目标入组 994 人开始时间: 2023年11月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
招募中
发起方
Jason Sperry
入组人数
994
试验地点
19
主要终点
24-hour mortality

研究概览

简要总结

The Prehospital Analgesia INtervention trial (PAIN) is a proposed 4 year (3-year enrollment) multicenter, prehospital, randomized, double-blind, clinical trial that will enroll approximately 994 patients at select LITES Network sites. The objective is to perform a prospective, interventional, randomized trial among prehospital trauma patients with compensated shock (SI≥0.9 or HR ≥115) and an indication for pain management, comparing patient centered outcomes following prehospital administration of ketamine hydrochloride versus fentanyl citrate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Transport after injury to a participating PAIN Trauma center
  • 2. Patient with compensated shock as defined by Shock Index (SI) ≥0.9 or Heart Rate (HR) ≥
  • Intravenous pain medication indicated (CPOT≥2, NRS≥5) prior to arrival at the trauma center

排除标准

  • No IV access
  • Age <18 years
  • Females <50 years of age
  • SBP>180 mmHg at time of enrollment
  • Advanced airway management prior to first dose administration
  • Known allergy to fentanyl citrate or ketamine hydrochloride
  • Known prisoner
  • Objection to study voiced by subject or family member at scene
  • Pain treatment contraindicated by local protocol
  • Wearing a "NO PAIN STUDY" bracelet

研究组 & 干预措施

Ketamine Hydrochloride

Experimental

2 blinded doses 2.5mg/ml ketamine hydrochloride in separately sealed pre-filled syringes Subjects will be administered the first dose over approximately 2 minutes via slow IV push. Pain assessment following administration will be obtained and recorded every 15 minutes. Redosing may occur after approximately 15 minutes if the subject has a qualifying pain score, there are no contraindications to pain medication per local protocol, and no exclusion criteria have been met.

干预措施: Ketamine Hydrochloride (Drug)

Fentanyl Citrate

Active Comparator

2 blinded doses 10mcg/ml in separately sealed pre-filled syringes Subjects will be administered the first dose over approximately 2 minutes via slow IV push. Pain assessment following administration will be obtained and recorded every 15 minutes. Redosing may occur after approximately 15 minutes if the subject has a qualifying pain score, there are no contraindications to pain medication per local protocol, and no exclusion criteria have been met.

干预措施: Fentanyl Citrate (Drug)

结局指标

主要结局

24-hour mortality

时间窗: trauma bay arrival through 24 hours

All cause mortality within 24 hours from time of trauma bay arrival

次要结局

  • Hypotension(from initial administration of PAIN study prehospital analgesia through hospital arrival)
  • Need for airway management(from initial administration of PAIN study prehospital analgesia through hospital arrival)
  • Number of analgesic doses necessary to reduce pain level to <5 NRS or CPOT less than 2(from initial administration of PAIN study prehospital analgesia through hospital arrival)
  • Prehospital pain assessment following analgesia(from initial administration of PAIN study prehospital analgesia through hospital arrival)
  • Hospital length of stay(from time of hospital admission to discharge)
  • Hypoxia(from initial administration of PAIN prehospital analgesia through hospital arrival)
  • Trauma bay arrival pain score(score assessed at time of arrival to trauma bay)
  • Survival to hospital discharge(administration of PAIN study prehospital analgesia through hospital discharge or death up to 30 days)
  • Ventilator free days(from administration of PAIN study prehospital analgesia through hospital discharge or death up to 30 days)
  • Long term opioid use(3 months (+/- 1 month) and 6 months (+/- 1 month) following trauma admission)
  • 24 hour opioid use(from initial administration of PAIN study prehospital analgesia through 24 hours)
  • Incidence of prehospital adverse events(from initial administration of PAIN study prehospital analgesia through hospital arrival)
  • Baseline Pain/Anxiety/PTSD screening(0 hours to 2 weeks from time of hospital admission)
  • Intensive Care Unit free days(from administration of PAIN study prehospital analgesia through hospital discharge or death up to 30 days)
  • Long term (6 month) outcome(6 months +/- 1 month following trauma admission)
  • Long Term Pain Assessment(At 3 and 6 months (+/- 1 month) after hospital arrival)

研究者

发起方
Jason Sperry
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jason Sperry

Professor

University of Pittsburgh

研究点 (19)

Loading locations...

相似试验